PlainBillCongress, translated.Legislation. Context. Public interest.Referred to the Subcommittee on Health.
Congressional Research Service
Version 00 · Introduced in House · Jul 9, 2004
Drug Importation Promotion and Safety Act - Amends the Federal Food, Drug, and Cosmetic Act to establish the Office of Drug Importation Promotion and Safety.
Allows a registered drug importation facility, pharmacy, Internet pharmacy, or wholesaler to import a Food and Drug Administration (FDA)-approved prescription drug from Canada or a permitted country.
Prohibits the commingling of domestic and imported prescription drugs.
Showing the opening paragraphs of the official summary.
Requires a pharmacy or Internet pharmacy that dispenses an imported prescription drug to label such drug accordingly.
Allows individuals to import prescription drugs from: (1) a registered Internet pharmacy; or (2) licensed pharmacies for personal use.
Allows the Secretary to suspend importation of a particular drug from a particular facility, pharmacy, wholesaler, or country.
Allows licensed Internet pharmacies to dispense prescription drugs. Sets forth licensing requirements for Internet pharmacies.
Makes interactive computer service providers and advertising service providers liable for violations under this Act if such a provider accepts advertising: (1) for a prescription drug from an unlicensed Internet pharmacy; or (2) stating that an individual does not need a prescription to obtain a prescription drug.
Requires the Secretary to: (1) require the adoption and use of electronic track and trace technology to identify each sale, purchase, or trade of a prescription drug; and (2) establish a network to provide prompt notification of counterfeit drugs and to facilitate the identification and reporting of such drugs.
Sets forth requirements for wholesalers, including requirements to identify the immediately previous distributor of record and all previous sales, purchases, or trades for imported prescription drugs.
People & committees
Rep. John, Christopher [D-LA-7] · D–LA
Legislative record
A procedural vote is different from passage. Passage in one chamber does not establish enactment. Explore the glossary.
Referred to the Subcommittee on Health.
Referred to the House Committee on Energy and Commerce.
Introduced in House
Introduced in House
Primary sources
Text links open the official source. We currently store references to these documents.
No related bills are listed in this snapshot. This does not establish whether the proposal has appeared in earlier Congresses.
Source last updated: Aug 18, 2025. Consult Congress.gov for the current record.
AI Conversation Starters
Choose a perspective, copy a prompt, and paste it into your preferred AI. Each prompt includes the bill version and available official source links, and asks for counterarguments as well as supporting evidence.
Analyze H.R.4790 as objectively as possible. Explain its main provisions, who would be affected, possible benefits and harms, implementation, exceptions, and uncertainties. Present the strongest arguments for and against it, and identify evidence needed to assess its public impact.
Examine H.R.4790 through a progressive lens, focusing on fairness, access, economic inequality, and effects on vulnerable communities. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and distinguish stated goals from demonstrated outcomes.
Examine H.R.4790 through a conservative lens, focusing on fiscal responsibility, institutional stability, federalism, and the scope of government. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and any provisions that challenge this perspective.
Examine H.R.4790 through a civil-liberties and limited-government lens. Consider individual rights, privacy, voluntary choice, accountability, and government power. Explain tradeoffs, possible safeguards, and the strongest counterarguments without assuming the proposal is beneficial or harmful.